IQE is the leading global outsource supplier of customized epitaxial wafers to the semiconductor industry.

Their technology is of most advanced like AFM means Atomic Force Microscopy and moves a minuscule cantilever over an objects surface, a sharp tip passes over dips or rises punched in the surface and reads out digital information. This technology is not going to slow down it is going to speed up and has to replace most existing forms of memory storage by virtue of capacity and size.

The future of nano-technology, these tiny/minute robots would need very small processors and most sure strained silicon could provide these.

The low share price is due to uncertainty as to when the cash will run out, but I don't think this will happen as cash is of 12 to 15M and NAV of 30p, and losses are going to drop on the next 3 month and we could have profits on the Q4 2004.

Latest news from the Chairman were" The Group remains confident that it is in a strong position within the outsourcing market, although the protection of its cash position is paramount.
With a broad product portfolio allowing the customer base to use IQE as a 'one stop shop', a large available production capacity and a strong balance sheet, the Board believes the Group will benefit strongly as the overall semiconductor industry recovers and will continue to strengthen its position as the leading outsource supplier of advanced wafer products to the sector. "

Nearly all the recent results have been encouraging. Q4 accounts are being completed (30th Dec 2002). IQE know where they stand, if things had got worse their would have been a trading statement by now, and with Amberwave (IQE's partner) increasing its Asian presence, this is a bullish trend and a good point to pick up the shares @ 4.25p

Intraday

5 month MA and Indicators

are you saying the level is now unjustified?
long(er) term i beg to differ

re - unjustified
the recent rise is

re - differ
you would alright as you are now holding

indeed, and have done for about 15 months .... shall def continue to hold and just possibly add if there are a couple of poor days

you have missed the top now, but you could have sold and buy back, lets say 130p and posibly 120p.

They were well ahead of the Bollinger Band @ 149p this morning

not trying to trade these, but far from impossible that i'll top up if sp drops back to about 120

well was 147 first post today was 138p last post is now 133p

Arguably 2 gaps closed.

Nice annotated chart in Shares Magazine:

318% up and still going (Shares Magazine article)

motley fool buy july. i am still in , if this share was on nasdaq, 126p very cheap, takeover rumours abound. BB

oh yes very cheap 123p now

Indicators still on the middle on the way down

120p is not far away

but if someone likes GAPs like it seems, then next is 85/90p

missed the major drop as was out all day until about 5
can't see a t/o but would be more than put out if there is no a sharp recovery either before or on the numbers and announcement from AAPL early next month

Today:

"IQE is one stock I'd buy and hold for the next five years"

http://www.fool.co.uk/investing/2017/08/20/iqe-plc-is-one-stock-id-buy-and-hold-for-the-next-five-years/

Copied from over the road - Edison Note.

posted elsewhere tonite by Jim Boyce. Might push IQE up in the morning?



Optical component makers spike on report of China Mobile tender

Aug. 23, 2017 4:13 PM ET|By: Jason Aycock, SA News Editor
A tender for optical components by China Mobile (CHL -0.2%) has forced an end-of-day spike for makers of those components.

NeoPhotonics (NYSE:NPTN) jumped 10.7%; Oclaro (NASDAQ:OCLR) rose 5.6%; Acacia (NASDAQ:ACIA) jumped 5.5%; and Applied Optoelectronics (NASDAQ:AAOI) rose 4.1% after a report by Rosenblatt's Jun Zhang pointed to the tender, part of a project to build 50,000-70,000 40G/100G ports, according to the note.

Finisar (NASDAQ:FNSR) jumped 3.3% and Lumentum (NASDAQ:LITE) rose 3%.

Huawei is likely to take 50% of the order, Zhang says -- and it makes up 18% of Oclaro's total revenue as well as 17% of Lumentum's and 11% of Finisar's, Bloomberg says.

IQE possible fall on results sept to 20p short tracker has 1.5% holding down S/P

IQE possible fall to 120 on results sept short tracker showing 1.5% BB

"Jessica Amir: Can you elaborate on the work that you’re doing with IQE, the UK semiconductor foundry?

Giles Bourne: We were doing some contract manufacturing for them and now it’s a full-blown collaborator. Now IQE don’t make consumer products, but they do, do large-scale volume manufacture of compound semiconductor materials. And we’re now working on a project with them, which is really applying our technology to non-LED applications.

https://www.finnewsnetwork.com.au/archives/finance_news_network167156.html

From an interview with boss of Australian company BluGlass, Posted elsewhere by 'Fullbright'

article today by Kevin Godbold:


Back in the tech-bubble madness of 2000, shares in IQE (LSE: IQE) briefly touched 750p. Today, after multi-bagging from its lows, the stock changes hands for around 141p, but I reckon it has a decent shot at fulfilling the potential seen by stock market speculators almost 20 years ago because the underlying business is growing fast.

The future of semiconductors
The company manufactures and supplies advanced wafer products and services to the semiconductor industry globally. Through a process and technology known as epitaxy, IQE combines different semiconducting elements to make more advanced semiconductor materials, which are called compound semiconductors.

According to the firm, many people in the industry believe the future of semiconductors will focus on combining the advanced properties of compound semiconductors with silicon in a hybrid technology known as Compound Semiconductors On Silicon – a complex technology in which IQE has been a pioneer for over 10 years.

The directors say the firm has accumulated a “powerful portfolio of intellectual property (IP) including patents and trade secrets.” They are optimistic and say the company’s strong pedigree in high tech manufacturing “uniquely positions the firm to commercialise this IP over the coming years and decades.”

Strong revenues growth
In a trading update on 20 July, the company told us it had seen strong growth in revenues in the first half, which the directors reckon is due to increased demand for Vertical Cavity Surface Emitting Laser (VCSEL) wafers for mass-market consumer applications. When the directors of any company use words such as ‘mass-market’ when describing demand for their products, it’s bound to stir the animal instincts of even the most conservative of investors!

The firm has galvanised itself into action to cope with what it expects will be higher levels of demand going forward. The directors reckon the start of the ramp up for VCSEL wafers marks an inflection point in the commercialisation of the technology. There they go again – inflexion point – another phrase that suggests the potential is huge and that profitable growth is about to make a quantum leap forward.

Multiple contract wins
Indeed, IQE has nailed down “multiple, multi-year contracts” towards the growth of VCSEL, which the directors say reflects the firm’s strong competitive advantages, technology leadership and proven track record in delivering wafers into high volume consumer markets. The development of an expansion plan comes hard on the heels of the firm’s higher investment during the first half of 2017, which itself was designed to prepare for higher levels of growth in the second half. Part of the expansion plan has led to IQE agreeing heads of terms for the lease of new premises in South Wales.

Chief executive Dr Drew Nelson said in July’s update that “the first half of 2017 has been a very exciting time for the IQE Group.” He reckons the firm has “multiple high-growth opportunities ahead,” and it almost went without saying that he expected to exceed market expectations for 2017. Unusually, he went further and thinks it possible “a more significant upgrade to current market expectations could be delivered for 2018.”

I couldn’t resist the improving long-term fundamental story here, so I bought some of the shares last week. However, with a forward price-to-earnings ratio running a little over 37 for 2018, this will be a scary ‘hold’ for me. We’ll find out more with the interim statement due on 5 September.

i sold 40% of my trading position this morning at a very adequate profit
if the markets chirp up tomorrow, and may well buy them back